Literature DB >> 10336594

Functional interleukin-5 activity in peripheral blood mononuclear cells from adolescents with mite antigen asthma in remission.

T Noma1, M Hayashi, Y Kawano, I Yoshizawa, Y Ishikawa, T Saeki, K Aoki, N Matsuura.   

Abstract

BACKGROUND: Asthma improves in most children during adolescence such that a small minority of patients exhibit clinically significant symptoms by the age of 20 years. OBJECTIVE AND METHODS: To investigate late allergic reactions, including eosinophil inflammation, associated with outgrowing mite antigen-induced bronchial asthma during adolescence, the relationship between clinical status and functional activity of interleukin (IL)-5 produced by Dermatophagoides farinae (Df)-stimulated peripheral mononuclear cells (PBMCs) in culture was assessed in mouse IL-3-dependent cells transfected with the human IL-5 receptor gene.
RESULTS: Activity of IL-5 spontaneously produced by PBMCs from either patients with mite-sensitive bronchial asthma or nonatopic control subjects was low. The activity of IL-5 produced by PBMCs stimulated with concanavalin A was significantly higher. Upon challenge with specific allergens, such as Df antigen, but not with irrelevant antigens, including ovalbumin, the in vitro activity was increased in patients with active disease and decreased in patients in remission.
CONCLUSION: Results suggest that the antigen-specific up-regulation of functional IL-5 activity in late allergic reactions is reduced in patients in remission and likely to result in an improvement in clinical status. The Df antigen may suppress Df-induced responses in patients with asthma in remission.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336594     DOI: 10.1046/j.1365-2222.1999.00584.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  4 in total

1.  Resident alveolar macrophages suppress, whereas recruited monocytes promote, allergic lung inflammation in murine models of asthma.

Authors:  Zbigniew Zasłona; Sally Przybranowski; Carol Wilke; Nico van Rooijen; Seagal Teitz-Tennenbaum; John J Osterholzer; John E Wilkinson; Bethany B Moore; Marc Peters-Golden
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

2.  Sophora flavescens Alkaloids and Corticosteroid Synergistically Augment IL-10/IL-5 Ratio with Foxp3-Gene-Epigenetic Modification in Asthma PBMCs.

Authors:  Ying Song; Zhen-Zhen Wang; Lixin Wang; Paul Faybusovich; Kamal Srivastava; Changda Liu; Jody Tversky; David Dunkin; Paula Busse; Xianqing Ren; Rachel Miller; Mingsan Miao; Xiu-Min Li
Journal:  J Asthma Allergy       Date:  2021-12-23

3.  Children With Asthma Have Impaired Innate Immunity and Increased Numbers of Type 2 Innate Lymphoid Cells Compared With Healthy Controls.

Authors:  Banafshe Hosseini; Bronwyn S Berthon; Malcolm R Starkey; Adam Collison; Rebecca F McLoughlin; Evan J Williams; Kristy Nichol; Peter Ab Wark; Megan E Jensen; Carla Rebeca Da Silva Sena; Katherine J Baines; Joerg Mattes; Lisa G Wood
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

4.  Interleukin-10 and interleukin-5 balance in patients with active asthma, those in remission, and healthy controls.

Authors:  Minako Tomiita; Eduardo Campos-Alberto; Masayuki Shima; Masanobu Namiki; Kazuo Sugimoto; Hiroyuki Kojima; Hiroko Watanabe; Kunio Sekine; Toshiyuki Nishimuta; Yoichi Kohno; Naoki Shimojo
Journal:  Asia Pac Allergy       Date:  2015-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.